Pyrimethamine PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Pyrimethamine PCD pharma franchise company in India, offering a focused range of 4 Pyrimethamine formulations manufactured at WHO-GMP certified facilities. We supply consistent, DCGI-approved antiparasitic products to franchise partners and distributors who need dependable stock and district-wise monopoly support.
What is Pyrimethamine?
Pyrimethamine is a folic acid antagonist that inhibits parasitic dihydrofolate reductase. It is used to treat toxoplasmosis and, in combination, certain forms of malaria. Learn more from the PubChem compound record.
Available Pyrimethamine Formulations
Our current Pyrimethamine portfolio spans 4 Pyrimethamine formulations available in the following forms: Suspension, Tablets. Every batch is quality tested and released under WHO-GMP controls to ensure uniform quality across supply cycles.
Therapeutic Applications
Pyrimethamine is indicated for toxoplasmosis and combination therapy of malaria. It is prescribed by infectious disease specialists and general physicians and is dispensed strictly on prescription under qualified medical supervision.
Why Pyrimethamine is a High-Potential Molecule for Distributors
As a specialised antiparasitic used in toxoplasmosis and malaria protocols, pyrimethamine serves a defined niche with limited competition.
Why Choose Cafoli Lifecare
Partners receive district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs, and the backing of a network of 1000+ franchise partners across India. Our supply reliability and compliance-first approach help you build a durable Pyrimethamine franchise business.
References
- PubChem: Pyrimethamine
- MedlinePlus: Pyrimethamine
- PubMed: Pyrimethamine research
Our formulations of Pyrimethamine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: